SK15052000A3 - Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob - Google Patents

Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob Download PDF

Info

Publication number
SK15052000A3
SK15052000A3 SK1505-2000A SK15052000A SK15052000A3 SK 15052000 A3 SK15052000 A3 SK 15052000A3 SK 15052000 A SK15052000 A SK 15052000A SK 15052000 A3 SK15052000 A3 SK 15052000A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
compounds
group
reacting
Prior art date
Application number
SK1505-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Keith Michael Devries
Philip Charles Levett
Joanna Teresa Negri
Albert Shaw Wood
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9924042.6A external-priority patent/GB9924042D0/en
Priority claimed from GB0018667A external-priority patent/GB0018667D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SK15052000A3 publication Critical patent/SK15052000A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SK1505-2000A 1999-10-11 2000-10-09 Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob SK15052000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924042.6A GB9924042D0 (en) 1999-10-11 1999-10-11 Process for thr preparation of pyrazolo[4,3-D]pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
GB0018667A GB0018667D0 (en) 2000-07-28 2000-07-28 Process for the preparation of pyrazolo [4,3-d] Pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
SK15052000A3 true SK15052000A3 (sk) 2003-01-09

Family

ID=26244761

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1505-2000A SK15052000A3 (sk) 1999-10-11 2000-10-09 Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob

Country Status (39)

Country Link
EP (1) EP1092720B1 (enExample)
JP (1) JP2001114783A (enExample)
KR (1) KR100395718B1 (enExample)
CN (1) CN1292379A (enExample)
AR (1) AR029767A1 (enExample)
AT (1) ATE286899T1 (enExample)
AU (1) AU6543600A (enExample)
BG (1) BG104840A (enExample)
BR (1) BR0004787A (enExample)
CA (1) CA2322995A1 (enExample)
CO (1) CO5251476A1 (enExample)
CZ (1) CZ20003754A3 (enExample)
DE (1) DE60017330D1 (enExample)
DZ (1) DZ3096A1 (enExample)
EA (1) EA003145B1 (enExample)
EE (1) EE200000537A (enExample)
EG (1) EG22775A (enExample)
GT (1) GT200000169A (enExample)
HR (1) HRP20000674A2 (enExample)
HU (1) HUP0003979A3 (enExample)
ID (1) ID27539A (enExample)
IL (1) IL138913A0 (enExample)
IN (1) IN190477B (enExample)
IS (1) IS5654A (enExample)
MA (1) MA25867A1 (enExample)
MX (1) MXPA00009936A (enExample)
NO (1) NO316072B1 (enExample)
NZ (1) NZ507431A (enExample)
OA (1) OA11495A (enExample)
PA (1) PA8504601A1 (enExample)
PE (1) PE20010682A1 (enExample)
PL (1) PL343140A1 (enExample)
SG (1) SG97950A1 (enExample)
SK (1) SK15052000A3 (enExample)
SV (1) SV2002000194A (enExample)
TN (1) TNSN00195A1 (enExample)
TR (1) TR200002959A2 (enExample)
UY (1) UY26388A1 (enExample)
YU (1) YU59100A (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
US6809200B2 (en) * 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP2006219373A (ja) * 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pde7阻害作用を有するピリジニルピラゾロピリミジノン誘導体
WO2007057316A2 (en) * 2005-11-16 2007-05-24 F. Hoffmann-La Roche Ag Novel process for the preparation of thoc
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
AP2013007070A0 (en) * 2011-02-23 2013-08-31 Pfizer Imidazo[5,1-f][1,2,4] triazines for the treatment of neurological disorders
EP3541787A1 (en) * 2016-11-21 2019-09-25 Adama Agan Ltd. Process for preparing methoxy methyl pyridine dicarboxylate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299633B6 (cs) * 1997-04-25 2008-09-24 Pfizer Inc. Pyrazolopyrimidinony, meziprodukty pro jejich výrobu a farmaceutické a veterinární kompozice na jejich bázi
ATE247117T1 (de) * 1998-04-20 2003-08-15 Pfizer Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera

Also Published As

Publication number Publication date
CZ20003754A3 (cs) 2002-06-12
MXPA00009936A (es) 2002-10-23
KR20010050935A (ko) 2001-06-25
DZ3096A1 (fr) 2004-06-20
TR200002959A2 (tr) 2001-07-23
GT200000169A (es) 2002-04-03
EA003145B1 (ru) 2003-02-27
IS5654A (is) 2001-04-12
TNSN00195A1 (fr) 2005-11-10
KR100395718B1 (ko) 2003-08-25
PE20010682A1 (es) 2001-07-04
AR029767A1 (es) 2003-07-16
MA25867A1 (fr) 2003-10-01
NO316072B1 (no) 2003-12-08
CN1292379A (zh) 2001-04-25
CA2322995A1 (en) 2001-04-11
ATE286899T1 (de) 2005-01-15
EA200000924A2 (ru) 2001-04-23
IN190477B (enExample) 2003-08-02
CO5251476A1 (es) 2003-02-28
PL343140A1 (en) 2001-04-23
UY26388A1 (es) 2001-05-31
HUP0003979A3 (en) 2002-03-28
NZ507431A (en) 2002-09-27
NO20005104D0 (no) 2000-10-10
EG22775A (en) 2003-08-31
JP2001114783A (ja) 2001-04-24
PA8504601A1 (es) 2002-02-21
BG104840A (bg) 2001-10-31
SV2002000194A (es) 2002-01-23
NO20005104L (no) 2001-04-17
EP1092720A2 (en) 2001-04-18
YU59100A (sh) 2003-10-31
EA200000924A3 (ru) 2001-06-25
IL138913A0 (en) 2001-11-25
OA11495A (en) 2004-05-05
HUP0003979A2 (hu) 2001-12-28
AU6543600A (en) 2001-04-12
EP1092720A3 (en) 2001-09-19
ID27539A (id) 2001-04-12
BR0004787A (pt) 2001-05-22
EE200000537A (et) 2001-06-15
HRP20000674A2 (en) 2001-08-31
HU0003979D0 (en) 2000-12-28
SG97950A1 (en) 2003-08-20
EP1092720B1 (en) 2005-01-12
DE60017330D1 (de) 2005-02-17

Similar Documents

Publication Publication Date Title
RS59100B1 (sr) Antitela usmerena protiv her-3 i njihove upotrebe
JP3834236B2 (ja) ピラゾロ〔4,3−d〕ピリミジン誘導体
CZ376799A3 (cs) Pyrazolopyrimidinony, které inhibují typ 5 cyklické guanosin 3',5'-monofosfatfosfodiesterasy (cGMP /DE5) pro léčení sexuální dysfunkce
US11286253B2 (en) Process for preparing aminopyrimidine derivatives
US10391099B2 (en) Method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease with a novel 2,5-substituted pyrimidines
SK15532000A3 (sk) Pyrazolopyrimidínové inhibítory cgmp pde5 na použitie na liečbu sexuálnych dysfunkcií, spôsob ich prípravy, medziprodukty a farmaceutický prostriedok s ich obsahom
SK138599A3 (en) Process for the preparation of pyrazolo[4,3-d] pyrimidin-7-ones and their intermaediates
SK15052000A3 (sk) Spôsob výroby pyrazolo[4,3-d]pyrimidin-7-ón-3-pyridylsulfonylových zlúčenín a medziprodukty pre tento spôsob
AU754962B2 (en) Process for the preparation of pyrazolo(4,3-d)pyrimidin-7- one compounds and intermediates thereof
Abbott et al. Fused mesoionic heterocycles: synthesis of [1, 2, 3] triazolo [1, 5-a] quinoline,[1, 2, 3] triazolo [1, 5-a] quinazoline,[1, 2, 3] triazolo [1, 5-a] quinoxaline and [1, 2, 3] triazolo [5, 1-c] benzotriazine derivatives
CA2585557C (en) Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors
US6809200B2 (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
MXPA99009326A (en) Procedure for the preparation of pirazolo [4,3-d] pyrimidin-7-onas and its intermed
HK1078574B (en) Pyrazolo [4,3-d] pyrimidine derivatives
HK1069577B (en) Pyrazolo [4,3-d] pyrimidine derivatives
MXPA00010388A (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction